SIE, like many other BIOTechs have lost their flavour of the month status and are now trading at bargain prices.
SIE was in the Aegis BlueBook Report OCt 2003 on the Healthcare Sector.
Has the potential to be a 10 bagger as their drugs for treating diabetes and Hepatitus have enormous worldwide application. Launching products all over the world in the next 1-2 years.
Potentialy a 10 bagger at these prices!!!!!
Check out the report for yourself at www.aer.com.au
Add to My Watchlist
What is My Watchlist?